US Bancorp DE Has $1.06 Million Stock Position in Balchem Co. (NASDAQ:BCPC)

US Bancorp DE lessened its stake in shares of Balchem Co. (NASDAQ:BCPC) by 19.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 6,477 shares of the basic materials company’s stock after selling 1,606 shares during the period. US Bancorp DE’s holdings in Balchem were worth $1,056,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of BCPC. Heritage Family Offices LLP boosted its position in shares of Balchem by 8.3% in the fourth quarter. Heritage Family Offices LLP now owns 1,420 shares of the basic materials company’s stock worth $231,000 after buying an additional 109 shares during the period. Inspire Investing LLC lifted its stake in Balchem by 4.9% in the 4th quarter. Inspire Investing LLC now owns 2,462 shares of the basic materials company’s stock worth $401,000 after acquiring an additional 114 shares in the last quarter. Westside Investment Management Inc. acquired a new stake in Balchem during the 3rd quarter worth about $27,000. SageView Advisory Group LLC grew its stake in Balchem by 3.8% during the 3rd quarter. SageView Advisory Group LLC now owns 4,653 shares of the basic materials company’s stock valued at $819,000 after acquiring an additional 169 shares in the last quarter. Finally, Portside Wealth Group LLC increased its holdings in shares of Balchem by 12.5% in the 3rd quarter. Portside Wealth Group LLC now owns 1,551 shares of the basic materials company’s stock valued at $273,000 after purchasing an additional 172 shares during the period. 87.91% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on BCPC shares. StockNews.com downgraded shares of Balchem from a “buy” rating to a “hold” rating in a research report on Tuesday, February 25th. Sidoti raised shares of Balchem to a “hold” rating in a research note on Tuesday, February 25th. Finally, HC Wainwright reaffirmed a “buy” rating and issued a $190.00 price target on shares of Balchem in a research note on Monday, February 24th.

Balchem Price Performance

NASDAQ BCPC opened at $175.69 on Monday. The company has a market cap of $5.72 billion, a P/E ratio of 44.70, a P/E/G ratio of 4.41 and a beta of 0.63. Balchem Co. has a 1 year low of $137.69 and a 1 year high of $186.03. The company has a current ratio of 1.99, a quick ratio of 1.16 and a debt-to-equity ratio of 0.19. The company has a fifty day simple moving average of $163.17 and a 200 day simple moving average of $169.84.

Balchem (NASDAQ:BCPC) last issued its quarterly earnings results on Friday, February 21st. The basic materials company reported $1.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.11 by ($0.08). Balchem had a net margin of 13.47% and a return on equity of 11.37%. The business had revenue of $240.00 million during the quarter, compared to analyst estimates of $239.96 million. On average, sell-side analysts predict that Balchem Co. will post 4.64 EPS for the current year.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.